Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.
Moreno-Monteagudo JA, Castro A, De Pedro A, Lorenzo JA, Fernández-Bermejo M, Lopez S, García-Buey L, Borque MJ, Pedreira JD, Moreno-Otero R. Moreno-Monteagudo JA, et al. Among authors: borque mj. Aliment Pharmacol Ther. 2002 Feb;16(2):243-9. doi: 10.1046/j.1365-2036.2002.01162.x. Aliment Pharmacol Ther. 2002. PMID: 11860407 Free article. Clinical Trial.
Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy.
Lo Iacono O, Castro A, Diago M, Moreno JA, Fernandez-Bermejo M, Vega P, García V, Carbonell P, Sanz P, Borque MJ, García-Buey L, García-Monzón C, Pedreira J, Moreno-Otero R. Lo Iacono O, et al. Among authors: borque mj. Aliment Pharmacol Ther. 2000 Apr;14(4):463-9. doi: 10.1046/j.1365-2036.2000.00713.x. Aliment Pharmacol Ther. 2000. PMID: 10759626 Free article.
Maintenance of T1 response as induced during PEG-IFNalpha plus ribavirin therapy controls viral replication in genotype-1 patients with chronic hepatitis C.
Trapero M, García-Buey L, Muñoz C, Vitón M, Moreno-Monteagudo JA, Borque MJ, Quintana NE, Moreno-Otero R. Trapero M, et al. Among authors: borque mj. Rev Esp Enferm Dig. 2005 Jul;97(7):481-90. doi: 10.4321/s1130-01082005000700003. Rev Esp Enferm Dig. 2005. PMID: 16262527 Free article. English, Spanish.
Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response.
Trapero-Marugán M, García-Buey L, Muñoz C, Quintana NE, Moreno-Monteagudo JA, Borque MJ, Fernández MJ, Salvanés FR, Medina J, Moreno-Otero R. Trapero-Marugán M, et al. Among authors: borque mj. Aliment Pharmacol Ther. 2006 Jul 1;24(1):117-28. doi: 10.1111/j.1365-2036.2006.02954.x. Aliment Pharmacol Ther. 2006. PMID: 16803610 Free article.
Treatment regimens for patients with chronic hepatitis C.
Trapero-Marugan M, González-Moreno L, Chaparro-Sánchez M, Moreno-Monteagudo JA, Borque MJ, Moreno-Otero R. Trapero-Marugan M, et al. Among authors: borque mj. Minerva Gastroenterol Dietol. 2008 Jun;54(2):209-17. Minerva Gastroenterol Dietol. 2008. PMID: 18319692 Review.
45 results